(Q44660109)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14624413%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Milrinone, a selective phosphodiesterase 3 inhibitor, stimulates lipolysis, endogenous glucose production, and insulin secretion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14624413%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

ChEBI release 2020-05-28

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14624413%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Peter Cheung

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14624413%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Guenther Boden

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14624413%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14624413%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14624413%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14624413%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14624413%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1496-1500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14624413%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Role of phosphodiesterase III in the antilipolytic effect of insulin in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Modulation of insulin secretion and glycemia by selective inhibition of cyclic AMP phosphodiesterase III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Measurement of size and turnover rate of body glucose pool by the isotope dilution method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Plasma free fatty acid and triglyceride turnover in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Leptin inhibits insulin secretion by activation of phosphodiesterase 3B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

A novel insulin secretagogue is a phosphodiesterase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Effect of type-selective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN-BD11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2803%2900271-3

10.1016/S0026-0495(03)00271-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14624413%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference